FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2934922306> ?p ?o ?g. }

• W2934922306 abstract "Sarcopenia, defined as low muscle mass and strength, is highly prevalent in patients undergoing chronic hemodialysis (HD). However, muscle function and muscle mass do not share the same clinical relevance. In fact, muscle strength was more closely associated with the risk of mortality in chronic HD patients than was muscle mass. Therefore, to identify the risk factors of muscle weakness is vital. Angiotensin II overexpression had been recognized to impair skeletal muscle strength. Accordingly, angiotensin II receptor blockers (ARBs) potentially possess a muscle protective effect. This cross-sectional study aimed to identify the factors associated with low muscle strength and to explore the relationship between ARB use and muscle strength in chronic HD patients.A total of 120 chronic HD patients, aged 63.3 ± 13.2 years, were included in this study. Basic characteristics, handgrip strength (HGS), body composition, and nutritional status were assessed, and blood samples for biochemical tests were obtained. We divided these participants into normal- and low HGS groups according to the consensus of the European Working Group on Sarcopenia in Older People (EWGSOP).We observed that 78 (65.0%) patients had low HGS. In our cohort, we found that height (r = 0.653; P < 0.001), weight (r = 0.496; P < 0.001), body mass index (r = 0.215; P = 0.020), skeletal muscle index (r = 0.562; P < 0.001), albumin (r = 0.197; P = 0.032), and serum creatinine (r = 0.544; P < 0.001) were positively and age (r = - 0.506; P < 0.001), subjective global assessment (SGA) score (r = - 0.392; P < 0.001), fractional clearance index for urea (Kt/V) (r = - 0.404; P < 0.001) and urea reduction ratio (URR) (r = - 0.459; P < 0.001) were negatively correlated with HGS. According to our analysis, age (Odds ratio, OR = 1.11, 95% confidence interval, 95% CI = 1.05-1.17, P < 0.001), HD duration (OR = 1.01, 95% CI = 1.00-1.02, P = 0.010), diabetes (OR = 13.33, 95% CI = 3.45-51.53, P < 0.001), Kt/V (OR = 1.61, 95% CI = 1.06-2.46, P = 0.027), and SGA score (OR = 1.19, 95% CI = 1.03-1.38, P = 0.017) were regarded as independent predictors of low HGS. In contrast, ARB use (OR = 0.25, 95% CI = 0.07-0.93, P = 0.039) was independently associated with preserved HGS in chronic HD patients, after adjustment for multiple confounding factors.Our study is the first report in chronic HD patients to indicate a potentially protective effect of ARB on muscle strength. However, further longitudinal follow-up and intervention studies are needed to confirm this finding." @default.
• W2934922306 created "2019-04-11" @default.
• W2934922306 creator A5032323678 @default.
• W2934922306 creator A5043642350 @default.
• W2934922306 creator A5045066458 @default.
• W2934922306 creator A5049707862 @default.
• W2934922306 creator A5059314796 @default.
• W2934922306 creator A5082871118 @default.
• W2934922306 creator A5083075778 @default.
• W2934922306 date "2019-02-14" @default.
• W2934922306 modified "2023-10-13" @default.
• W2934922306 title "Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients" @default.
• W2934922306 cites W1929610814 @default.
• W2934922306 cites W1973808426 @default.
• W2934922306 cites W1980998405 @default.
• W2934922306 cites W1983155251 @default.
• W2934922306 cites W1986772336 @default.
• W2934922306 cites W2002881206 @default.
• W2934922306 cites W2007712741 @default.
• W2934922306 cites W2013455727 @default.
• W2934922306 cites W2013458853 @default.
• W2934922306 cites W2016617545 @default.
• W2934922306 cites W2047230325 @default.
• W2934922306 cites W2053437995 @default.
• W2934922306 cites W2054774517 @default.
• W2934922306 cites W2069441645 @default.
• W2934922306 cites W2099368300 @default.
• W2934922306 cites W2102902846 @default.
• W2934922306 cites W2104516645 @default.
• W2934922306 cites W2109355862 @default.
• W2934922306 cites W2110957605 @default.
• W2934922306 cites W2118858452 @default.
• W2934922306 cites W2122540540 @default.
• W2934922306 cites W2123632642 @default.
• W2934922306 cites W2128291192 @default.
• W2934922306 cites W2128801044 @default.
• W2934922306 cites W2128889033 @default.
• W2934922306 cites W2129871296 @default.
• W2934922306 cites W2136519953 @default.
• W2934922306 cites W2137415798 @default.
• W2934922306 cites W2137597475 @default.
• W2934922306 cites W2137632524 @default.
• W2934922306 cites W2140092212 @default.
• W2934922306 cites W2150177691 @default.
• W2934922306 cites W2156631635 @default.
• W2934922306 cites W2166636130 @default.
• W2934922306 cites W2225705338 @default.
• W2934922306 cites W2227033802 @default.
• W2934922306 cites W2320860130 @default.
• W2934922306 cites W2410812192 @default.
• W2934922306 cites W2528297355 @default.
• W2934922306 cites W2579465591 @default.
• W2934922306 cites W2596804147 @default.
• W2934922306 cites W2602353059 @default.
• W2934922306 cites W4241269166 @default.
• W2934922306 doi "https://doi.org/10.1186/s12882-019-1223-3" @default.
• W2934922306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6376758" @default.
• W2934922306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30764799" @default.
• W2934922306 hasPublicationYear "2019" @default.
• W2934922306 type Work @default.
• W2934922306 sameAs 2934922306 @default.
• W2934922306 citedByCount "18" @default.
• W2934922306 countsByYear W29349223062019 @default.
• W2934922306 countsByYear W29349223062020 @default.
• W2934922306 countsByYear W29349223062021 @default.
• W2934922306 countsByYear W29349223062022 @default.
• W2934922306 countsByYear W29349223062023 @default.
• W2934922306 crossrefType "journal-article" @default.
• W2934922306 hasAuthorship W2934922306A5032323678 @default.
• W2934922306 hasAuthorship W2934922306A5043642350 @default.
• W2934922306 hasAuthorship W2934922306A5045066458 @default.
• W2934922306 hasAuthorship W2934922306A5049707862 @default.
• W2934922306 hasAuthorship W2934922306A5059314796 @default.
• W2934922306 hasAuthorship W2934922306A5082871118 @default.
• W2934922306 hasAuthorship W2934922306A5083075778 @default.
• W2934922306 hasBestOaLocation W29349223061 @default.
• W2934922306 hasConcept C104849204 @default.
• W2934922306 hasConcept C126322002 @default.
• W2934922306 hasConcept C134018914 @default.
• W2934922306 hasConcept C164705383 @default.
• W2934922306 hasConcept C2776214593 @default.
• W2934922306 hasConcept C2776418732 @default.
• W2934922306 hasConcept C2778063415 @default.
• W2934922306 hasConcept C2779959927 @default.
• W2934922306 hasConcept C2780221984 @default.
• W2934922306 hasConcept C2780306776 @default.
• W2934922306 hasConcept C2908929049 @default.
• W2934922306 hasConcept C71924100 @default.
• W2934922306 hasConcept C84393581 @default.
• W2934922306 hasConceptScore W2934922306C104849204 @default.
• W2934922306 hasConceptScore W2934922306C126322002 @default.
• W2934922306 hasConceptScore W2934922306C134018914 @default.
• W2934922306 hasConceptScore W2934922306C164705383 @default.
• W2934922306 hasConceptScore W2934922306C2776214593 @default.
• W2934922306 hasConceptScore W2934922306C2776418732 @default.
• W2934922306 hasConceptScore W2934922306C2778063415 @default.
• W2934922306 hasConceptScore W2934922306C2779959927 @default.
• W2934922306 hasConceptScore W2934922306C2780221984 @default.
• W2934922306 hasConceptScore W2934922306C2780306776 @default.
• W2934922306 hasConceptScore W2934922306C2908929049 @default.

• next